References
- Centers for Disease Control and PreventionBlood DisordersUDC Data Reports https://www2a.cdc.gov/ncbddd/htcweb/UDC_Report/UDC_Report.aspAccessed June 18, 2012
- DarbySCKeelingDMSpoonerRJThe incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–1999J Thromb Haemost2004271047105415219185
- YoungGMcDanielMNugentDJProphylactic recombinant factor VIIa in haemophilia patients with inhibitorsHaemophilia200511320320715876264
- RooversJPvan der BomJGvan der VaartCHvan LeeuwenJHScholtenPCHeintzAPA randomized comparison of post-operative pain, quality of life, and physical performance during the first 6 weeks after abdominal or vaginal surgical correction of descensus uteriNeurourol Urodyn200524433434015924355
- BrownJThorpeHNappVAssessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancerJ Clin Oncol200523307417742716157935
- PuhanMAGuyattGHArmstrongDValidation of a symptom diary for patients with gastro-oesophageal reflux diseaseAliment Pharmacol Ther200623453154116441474
- AbramsPArtibaniWGajewskiJBHussainIAssessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measuresUrology200668 Suppl 2172816908337
- Van KerrebroeckPEKelleherCJCoyneKSKoppZBrodskyMWangJTCorrelations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placeboHealth Qual Life Outcomes200971319226471
- HaideraliAMendittoLGoodMTeitelbaumAWegnerJImpact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. populationSupport Care Cancer201119684385120532923
- YoungGShapiroADWalshCEGruppoRAGutRZCooperDLPatient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)Haemophilia201218339239922171621
- ValentinoLAWalshCERedingMTYoungGALevendoglu-TugalOCooperDLPatient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Hemophilia (DOSE)Haemophilia201218455456022348407
- NeufeldEJRechtMSabioHEffect of acute bleeding on daily quality of life (QOL) assessments in patients with congenital hemophilia with inhibitors and their families: observations from the Dosing Observational Study in Hemophilia (DOSE)Value Health201215691692522999142
- World Medical AssociationDeclaration of Helsinki: ethical principles for medical research involving human subjects http://www.wma.net/en/30publications/10policies/b3/Accessed June 18, 2012
- Guidelines for good pharmacoepidemiology practices (GPP)Pharmacoepidemiol Drug Saf200817220020817868186
- LoveLHome therapy forms – why don’t they come back?Haemophilia19962Suppl 148